1. Taiwan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Unicon Optical Co., Ltd.

Unicon Optical Co., Ltd.

TTPEX:4150
1.59
TWD
-0.21
(-11.67%)
714.01MMarket Cap
Unicon Optical Co., Ltd.
TPEX:4150
(Taipei Exchange)

Recent

price

1.59

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
TWD
13.76
27.39
25.8
13.39
18.98
24.42
11.81
13.68
10.69
14.46
12.88
6.25
5.61
5.74
6.18
4.36
- -
Revenue per Share
-5.49
0.21
-6.1
-11.66
-4.12
-5.15
-5.58
-3.91
-3.51
-1.86
-4.1
-2.04
-1.72
1.69
-1.18
-1.86
- -
Basic EPS, GAAP
-18.07
-9.12
-8.58
-10.83
-0.79
-3.92
-7.31
-4.67
-3.91
0.64
-1.27
-1.87
0.1
-0.15
-0.27
-1.66
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
18.76
25.97
20.58
18.77
18.38
15.18
12.02
10.23
11.72
10
6.3
6.39
4.68
6.35
5.21
3.31
2.47
Book Value per Share
18.71
25.83
20.38
18.63
18.21
14.52
10.36
9
11.3
9.45
5.89
6.22
4.5
6.22
5.18
3.27
2.41
Tangible Book Value per Share
14
16
16
20
24
26
48
60
76
85
86
144
147
147
147
147
147
Basic Weighted Avg Shares
188
427
426
266
458
630
568
821
807
1,236
1,114
898
825
846
909
641
- -
Sales/Revenue/Turnover
-39.15
0.4
-23.81
-85.13
-22.67
-6.7
-43.68
-27.5
-20.68
-10.82
-39.15
-32.62
-25.55
-13.76
-14.07
-37.36
- -
Operating Margin (%)
30
39
59
65
58
49
103
123
125
152
173
157
146
127
112
62
- -
Depreciation Expense
-75
3
-101
-232
-99
-133
-268
-234
-265
-159
-355
-293
-254
249
-174
-274
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.6
- -
- -
- -
Effective Tax Rate (%)
-39.86
0.75
-23.64
-87.09
-21.69
-21.1
-47.22
-28.56
-32.87
-12.86
-31.86
-32.65
-30.73
29.43
-19.15
-42.73
- -
Profit Margin (%)
-2
155
92
134
187
43
137
116
485
39
-287
29
-33
126
390
121
-12
Working Capital
15
164
178
145
132
132
140
119
118
377
370
213
170
135
284
271
254
LT Debt
295
452
346
441
493
353
682
670
1,006
860
550
940
688
934
767
487
363
Total Equity
- -
-0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-10.48
- -
- -
- -
Return on Invested Capital (%)
- -
1.32
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
22.93
- -
- -
- -
Return on Capital (%)
-30.32
0.86
-25.19
-58.9
-21.43
-31.67
-51.78
-34.62
-31.63
-16.99
-50.21
-39.37
-31.15
30.68
-20.47
-43.67
- -
Return on Common Equity (%)

Capital Structure

TWD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
27
127
205
LT Borrowings
175
171
165
LT Finance Leases
98
100
89
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
147
147
147
Market Capitalization
1,546
1,159
714

Working Capital

TWD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
472
421
359
Cash, Cash Equivalents & STI
178
149
96
Accounts Receivable, Net
77
121
117
Inventories
199
133
127
Total Current Liabilities
219
299
371
Payables & Accruals
- -
- -
- -
ST Debt
27
127
205
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.65%
5.13%
-36.5%
Free Cash Flow
20.4%
78.02%
525.92%
Net Income, GAAP
-15.61%
-68.33%
57.31%
Sales/Revenue/Turnover
2.92%
-9.39%
-29.5%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
909
2025
- -
- -
641
2026
- -
- -
- -

Semi-annual Earnings Per Share

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-1.18
2025
- -
- -
-1.86
2026
- -
- -
- -

Semi-annual Dividends Per Share

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Unicon Optical Co., Ltd. engages in the research, development, design, manufacture, and sale of soft contact lenses. Its product portfolio includes daily disposable and monthly disposable soft contact lenses; basic blue tint lenses; color lenses; silicone hydrogel lenses; myopia and farsighted lenses for vision correction; makeup contact lenses; hydrophobic lenses; drug-release contact lenses; and corneal photochromic lenses that change iris color. The company offers these products under its own brand UNICON and also manufactures semi-finished dry lenses for other firms. Founded in 1992 and headquartered in Hsinchu, Taiwan, Unicon operates primarily in Taiwan and Southeast Asia. In recent years, the company has reinforced its position among the top disposable color contact lens manufacturers in these regions. The latest strategic developments include expanding product lines with advanced lens technologies such as hydrophobic and drug-release variants while maintaining strong commitments to innovation and quality. Unicon serves both domestic and international markets, targeting consumers requiring vision correction and specialty lenses for both medical and cosmetic purposes. The company continues focusing on professional research and manufacturing excellence to strengthen its market presence and technological edge in optical products.